Your browser doesn't support javascript.
loading
The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis.
Chow, Bryna S M; Koulis, Christine; Krishnaswamy, Pooja; Steckelings, Ulrike M; Unger, Thomas; Cooper, Mark E; Jandeleit-Dahm, Karin A; Allen, Terri J.
Affiliation
  • Chow BS; JDRF Danielle Alberti Memorial Centre for Diabetic Complications, Diabetic Complications Division, Baker IDI Heart and Diabetes Research Institute, 75 Commercial Road, P. O. Box 6492, Melbourne, VIC, 3004, Australia.
  • Koulis C; JDRF Danielle Alberti Memorial Centre for Diabetic Complications, Diabetic Complications Division, Baker IDI Heart and Diabetes Research Institute, 75 Commercial Road, P. O. Box 6492, Melbourne, VIC, 3004, Australia.
  • Krishnaswamy P; JDRF Danielle Alberti Memorial Centre for Diabetic Complications, Diabetic Complications Division, Baker IDI Heart and Diabetes Research Institute, 75 Commercial Road, P. O. Box 6492, Melbourne, VIC, 3004, Australia.
  • Steckelings UM; IMM-Department of Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark.
  • Unger T; School for Cardiovascular Diseases, Maastricht University, Maastricht, the Netherlands.
  • Cooper ME; JDRF Danielle Alberti Memorial Centre for Diabetic Complications, Diabetic Complications Division, Baker IDI Heart and Diabetes Research Institute, 75 Commercial Road, P. O. Box 6492, Melbourne, VIC, 3004, Australia.
  • Jandeleit-Dahm KA; JDRF Danielle Alberti Memorial Centre for Diabetic Complications, Diabetic Complications Division, Baker IDI Heart and Diabetes Research Institute, 75 Commercial Road, P. O. Box 6492, Melbourne, VIC, 3004, Australia.
  • Allen TJ; JDRF Danielle Alberti Memorial Centre for Diabetic Complications, Diabetic Complications Division, Baker IDI Heart and Diabetes Research Institute, 75 Commercial Road, P. O. Box 6492, Melbourne, VIC, 3004, Australia. terri.allen@bakeridi.edu.au.
Diabetologia ; 59(8): 1778-90, 2016 08.
Article in En | MEDLINE | ID: mdl-27168137

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Thiophenes / Receptor, Angiotensin, Type 2 / Diabetes Mellitus, Experimental / Atherosclerosis / Angiotensin II Type 2 Receptor Blockers Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans / Male Language: En Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Thiophenes / Receptor, Angiotensin, Type 2 / Diabetes Mellitus, Experimental / Atherosclerosis / Angiotensin II Type 2 Receptor Blockers Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans / Male Language: En Year: 2016 Type: Article